Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.
about
STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid ArthritisSerum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis.Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children.Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients?Steroid therapy and renal dysfunction are independently associated with serum levels of matrix metalloproteinase-3 in patients with rheumatoid arthritis.Selenium Reduces Early Signs of Tumor Necrosis Factor Alpha-Induced Meniscal Tissue Degradation.Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials.Assessment of murine collagen-induced arthritis by longitudinal non-invasive duplexed molecular optical imaging.C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab.Preventive effects of dietary hydroxytyrosol acetate, an extra virgin olive oil polyphenol in murine collagen-induced arthritis.
P2860
Q28554987-E0EF7CFF-7138-4B37-96C2-E27D7F95FF0CQ34043042-2F5766FA-0499-4008-9D6D-31A203A87849Q35768186-550632FF-3049-4FC4-BF3D-57E75AA5E39EQ36164886-C81E7A99-698C-46B6-8249-14C1B601A3C9Q36907478-2E3B5E57-0A12-44CA-8CBF-C0E86F56935AQ37181580-0FAE4713-375A-4860-A5F4-BCD87374823EQ37679653-5EB49B23-48E7-4BC0-ADD9-7D8653C75F42Q38653180-FA8581E5-2B9E-43BE-8365-D86E2F4B7F79Q38805261-DAFDDF8F-9700-4C44-9888-58460EB630F3Q40169515-E9D8AD1F-ACA9-4A85-8B18-BB14CB5F35C1Q40948096-84084B8A-DA7B-4695-8E1E-FF1ADFF50E2CQ47129297-1D6C71A3-5DDD-4F43-AE4D-EC1CA478DD1BQ50208697-3EBDAFBE-2FAA-4562-8416-8E0312BF47F0Q50933999-C6600185-43E3-4B7A-B319-0E51E771416A
P2860
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Serum matrix metalloproteinase ...... in early rheumatoid arthritis.
@en
type
label
Serum matrix metalloproteinase ...... in early rheumatoid arthritis.
@en
prefLabel
Serum matrix metalloproteinase ...... in early rheumatoid arthritis.
@en
P2093
P2860
P50
P356
P1476
Serum matrix metalloproteinase ...... in early rheumatoid arthritis
@en
P2093
Bridget Hodkinson
Mahmood M T M Ally
Mohammed Tikly
P2860
P304
P356
10.1155/2013/183653
P577
2013-04-07T00:00:00Z